Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease.
作者:
DOI
10.1177/20420188211001160
PMID
33854753
发布时间
2024-08-31
- 浏览0
Therapeutic advances in endocrinology and metabolism
20420188211001160页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文